๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Liver Disease Chronic

Phase 4, Double-blind Study Evaluating the Response on Computed Tomography (CT) Lung Density Decline Rates of Respreeza / Zemaira Weekly for 3 Years in Adults With alpha1 Antitrypsin Deficiency (AATD) NCT07326592Phase 42 sites๐Ÿ“ Aalborg๐Ÿ“ Vejle CSL Behring ยท Tests: CE1226 Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B NCT06680232Phase 17 sites๐Ÿ“ Boston๐Ÿ“ Clichy๐Ÿ“ Hong Kong Precision BioSciences, Inc. ยท Tests: PBGENE-HBV Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance NCT06779864n/a1 site๐Ÿ“ Beijing Beijing Friendship Hospital Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health Adaptability of an Undetectable = Untransmissible Model for HBV NCT07449091n/a1 site๐Ÿ“ New York NYU Langone Health Study on the Quantitative Assessment of the Risk of Hepatocellular Carcinoma in Patients With Chronic Liver Disease Using Multi-parameter Magnetic Resonance Imaging NCT06060769n/a1 site๐Ÿ“ Zhuhai Fifth Affiliated Hospital, Sun Yat-Sen University An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis NCT05335603n/a1 site๐Ÿ“ Hvidovre University of Copenhagen SASL Swiss Cirrhosis Cohort NCT06092385n/a10 sites๐Ÿ“ Lugano๐Ÿ“ Basel๐Ÿ“ Bern University Hospital, Basel, Switzerland ยท Tests: Data collection Belimumab in Autoimmune Hepatitis NCT06381453Phase 26 sites๐Ÿ“ Calgary๐Ÿ“ Vancouver๐Ÿ“ Hamilton University Health Network, Toronto ยท Tests: Belimumab Auto-Injector [Benlysta] Host-Diet-Gut Interaction Post Vegan Diet in Pediatric Autoimmune Hepatitis. NCT07118657NA1 site๐Ÿ“ New Delhi Institute of Liver and Biliary Sciences, India ยท Tests: Vegan Diet, Standard Diet 2D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices NCT07122622n/a1 site๐Ÿ“ Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS EUS-guided Portal Pressure Gradient (PPG) Measurement: a Potential Alternative to the Traditional HVPG NCT06863012NA1 site๐Ÿ“ Barcelona Fundacio Privada Mon Clinic Barcelona ยท Tests: Endoscopic Ultrasound-Guided Portal Pressure Gradient (EUS-PPG) Measurement, Hepatic Venous Pressure Gradient (HVPG) Meโ€ฆ Cessation of Long Term NAs vs. Keeping on NAs Among CHB Patients (CNAVK) NCT03792919Phase 41 site๐Ÿ“ Hong Kong Humanity & Health Medical Group Limited ยท Tests: Stop current treatment (anti-HBV neucleos(t)ides), Keep current treatment (anti-HBV neucleos(t)ides) A Multicenter Study of AHB-137 Injection Combined With Other Hepatitis B Drugs NCT07069569Phase 214 sites๐Ÿ“ Beijing๐Ÿ“ Chongqing๐Ÿ“ Fuzhou Ausper Biopharma Co., Ltd. ยท Tests: AHB-137, Peg-IFN, Hepatitis B Vaccine Long-term Outcomes of Anti-viral Therapies in Patients With Chronic Viral Hepatitis B NCT04896255n/a1 site๐Ÿ“ Shanghai Huashan Hospital ยท Tests: peginterferon alpha based regimen, nucleos(t)ide A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2) NCT07200908Phase 357 sites๐Ÿ“ Graz๐Ÿ“ Sankt Pรถlten๐Ÿ“ Brno Mirum Pharmaceuticals, Inc. ยท Tests: Brelovitug 300 mg, Bulevirtide 2 mg and Brelovitug - 300 mg TLR-9 Adjuvanted Vaccination for Chronic Hepatitis B NCT04843852Phase 11 site๐Ÿ“ Baltimore University of Maryland, Baltimore ยท Tests: Hepatitis B Vaccine Recombinant, Adjuvanted Intramuscular Solution [HEPLISAV-B] Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b NCT02883647n/a1 site๐Ÿ“ Guangzhou Third Affiliated Hospital, Sun Yat-Sen University ยท Tests: Entecavir or Tenofovir Strategic Treatment Reduction in Very Early Liver Disease With 4 Weeks Sofosbuvir Plus Glecepravir-pibrentasvir NCT03855917Phase 43 sites๐Ÿ“ Darlinghurst๐Ÿ“ Sydney๐Ÿ“ Adelaide Kirby Institute ยท Tests: Sofosbuvir 400mg [Sovaldi], Glecaprevir/pibrentasvir (300mg/120mg) SSM Predicts Outcomes of CLD Inpatients With Acute Liver Injury NCT06173947n/a1 site๐Ÿ“ Guangzhou Nanfang Hospital, Southern Medical University ยท Tests: FibroScanยฎ Expert 630 Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project. NCT07169656n/a162 sites๐Ÿ“ Anyang๐Ÿ“ Anyang๐Ÿ“ Anyang The First Affiliated Hospital of Zhengzhou University ยท Tests: ETV,TDF,TAF,TMF, Peginterferon ฮฑ-2b injection Exploring the Genome-wide Association Study of the Population With Clinical Cure Advantage in the Treatment of Chronic Hepatitis B With Long-acting Interferon NCT06696664n/a1 site๐Ÿ“ Beijing Minghui Li ยท Tests: PEG-IFN-ฮฑ Prognosis of Cirrhotic Patients Admitted to the General Intensive Care Unit Between 2014 and 2024: a Regional Retrospective Multicentre Cohort Study NCT06948565n/a1 site๐Ÿ“ Besanรงon Centre Hospitalier Universitaire de Besancon ยท Tests: observational study CytOSorb TreatMent Of Critically Ill PatientS Registry NCT05146336n/a28 sites๐Ÿ“ Klagenfurt๐Ÿ“ Vienna๐Ÿ“ Aachen CytoSorbents, Inc ยท Tests: CytoSorb Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus NCT07096193Phase 1, Phase 228 sites๐Ÿ“ Anaheim๐Ÿ“ La Jolla๐Ÿ“ Louisville Gilead Sciences ยท Tests: GS-4321, GS-4321 Placebo, GS-4321 A Prospective/Retrospective, Observational Follow-up Study of Chronic Hepatitis B With Non-alcoholic Fatty Liver Disease. NCT05255978n/a1 site๐Ÿ“ Wuhan Qin Ning Non-Invasive Model for Fibrosis Regression in HBV Patients NCT06874127n/a1 site๐Ÿ“ Beijing Beijing Friendship Hospital ยท Tests: Nucleos(t)ide Analogs (NA) A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD) NCT06619561Phase 226 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Orange Deciphera Pharmaceuticals, LLC ยท Tests: Vimseltinib A Trial of Post-Discharge Transitional Care for Patients With Chronic Liver Disease NCT05733832NA4 sites๐Ÿ“ Chicago๐Ÿ“ Indianapolis๐Ÿ“ Ann Arbor Indiana University ยท Tests: Transitional Liver Clinic (TLC) SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus NCT06364930Phase 41 site๐Ÿ“ Hong Kong Chinese University of Hong Kong ยท Tests: Dapagliflozin 10mg Tab, Placebo 10mg Tab
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy